Monitor for actual execution of the sale on Form 4 filings. A large institutional insider signaling intent to sell over $35M in stock is a notable overhang. The stock has shown mixed historical reaction to prior filings, but a large sell signal from a key pre-IPO holder warrants caution.
SEPN drugs
SEPN drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 13 $45.14entry
- T+1 · 3mo ago −1.42%α −1.22% · $44.50
- T+5 · 3mo ago −9.64%α −7.67% · $40.79
- T+20 · 2mo ago −14.69%α −12.94% · $38.51
- T+60 · 11d ago +8.22%α +13.69% · $48.85
Price Chart
How similar events traded
Executive Summary
RA Capital Nexus Fund III, L.P., a major pre-IPO institutional investor in Septerna, filed a Form 144 on August 12, 2026, indicating intent to sell 746,500 shares of common stock. At the filing, the approximate market value of the proposed sale was $35,973,835. This represents a significant partial exit by a large insider affiliate, though the sale may not be executed immediately.
Key Facts
- RA Capital Nexus Fund III, L.P. filed Form 144 to sell 746,500 shares of Septerna common stock.
- Approximate market value of the proposed sale is $35,973,835.
- Shares were acquired in IPO/private rounds on 10/25/2024 and 05/24/2024.
- The filing is an advance notice of intent to sell; the sale may or may not occur.
- RA Capital is a significant pre-IPO investor, and this filing signals a potential partial exit.
Financial Impact
Proposed sale of 746,500 shares valued at approximately $35.97 million, representing roughly 1.6% of Septerna's $2.2B market cap.
Risk Factors
- Insider selling by a major pre-IPO investor may signal reduced conviction or a need for liquidity.
- The proposed sale represents a material overhang of ~1.6% of market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001178937-26-000041 |
| Document: 0001178937-26-000041-index.html | 0001178937-26-000041 |
| Document: 0001178937-26-000041.txt | 0001178937-26-000041 |
Track record
25 reports on SEPN
6 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $42.60 −0.00% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $42.60 −0.00% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $42.60 +1.77% settles Nov 19
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $42.60 +18.61% settles Nov 17
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $42.60 −11.03% ▲ +1.42% +2.33% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $42.60 −11.03% ▲ +1.42% +2.33% vs SPY
- Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $42.60 +10.62% ▲ +0.47% +0.69% vs SPY
- Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $42.60 +15.92% ▲ +7.62% +8.83% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers